Mannitol as an Excipient for Lyophilized Injectable Formulations.

Bulking agent Differential scanning calorimetry (DSC) Excipients Hydrate(s) Injectables Lyophilization Mannitol Polymorphs Sucrose Trehalose X-ray Powder diffraction (XRD)

Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
01 2023
Historique:
received: 11 06 2022
revised: 19 08 2022
accepted: 20 08 2022
pubmed: 29 8 2022
medline: 21 12 2022
entrez: 28 8 2022
Statut: ppublish

Résumé

The review summarizes the current state of knowledge of mannitol as an excipient in lyophilized injectable small and large molecule formulations. When compared with glycine, the physicochemical properties of mannitol make it a desirable and preferred bulking agent. Though mannitol is a popular bulking agent in freeze-dried formulations, its use may pose certain challenges such as vial breakage or its existence as a metastable crystalline hemihydrate in the final cake, necessitating appropriate mitigation strategies. The understanding of the phase behavior of mannitol in aqueous systems, during the various stages of freeze-drying, can be critical for the optimization of freeze-drying cycle parameters in multi-component formulations. Finally, using a decision tree as a guiding tool, we demonstrate the use of orthogonal techniques for attaining a stable and cost-effective lyophilized drug product containing mannitol.

Identifiants

pubmed: 36030846
pii: S0022-3549(22)00366-5
doi: 10.1016/j.xphs.2022.08.029
pii:
doi:

Substances chimiques

Excipients 0
Mannitol 3OWL53L36A
Sucrose 57-50-1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-35

Informations de copyright

Copyright © 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interests The authors declare no competing financial interest.

Auteurs

Seema Thakral (S)

Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States of America. Electronic address: seema.thakral@boehringer-ingelheim.com.

Jayesh Sonje (J)

Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States of America.

Bhushan Munjal (B)

Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States of America.

Bakul Bhatnagar (B)

Pfizer Inc., BioTherapeutics, Pharmaceutical Sciences, 1 Burtt Road, Andover, MA 01810, United States of America.

Raj Suryanarayanan (R)

Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, United States of America. Electronic address: surya001@umn.edu.

Articles similaires

Animals Rumen Methane Fermentation Cannabis
Phosphatidylcholine-Sterol O-Acyltransferase Flavonoids Humans Allosteric Regulation Molecular Dynamics Simulation
Flurbiprofen Tablets Administration, Oral Drug Compounding Solubility

Classifications MeSH